drugset / Trial / NCT04029467
Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Patients undergoing Partial or total mastectomy with axillary LN dissection will receive prior to induction of general anaesthesia ESP block at T4 level at the same side of the surgery. one group will receive ropivacaine 0.375% and the other will get ropivacaine 0.375% with dexmedetomidine 0.5mcg/kg as an adjuvant. time to first narcotic requirement will be documented and therefore an assessment of the duration of action of the block will be made
Timeline
- Start
- 2019-07-17
- Primary completion
- 2021-07-17
- Completion
- 2022-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Other |